MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Canadian Journal of Health Technologies
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

660 results · 1 filter active ·
Results by year
20212025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
660 works in the cohort · of 4,299,418page 9 of 14

Labels cover 1 of 660 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 660 of 660 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

aboutno affunlabeled
Nivolumab (Opdivo)
Reimbursement Team
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Olaparib (Lynparza)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Guselkumab (Tremfya)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Tralokinumab (Adtralza)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
fundaboutno affunlabeled
Quetiapine for Major Depressive Disorder
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Quetiapine for Insomnia
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Psychology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Dupilumab (Dupixent)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
fundaboutno affunlabeled
Lurbinectedin (Zepzelca)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Inclisiran (Leqvio)
Reimbursement Team
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Amivantamab (Rybrevant)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Roflumilast (Zoryve)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Patiromer (Veltassa)
Reimbursement Team
2021· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Daridorexant (Quviviq)
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Neuroscience
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Inebilizumab (Uplizna)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Efanesoctocog Alfa (ALTUVIIIO)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Exagamglogene Autotemcel (Casgevy)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Leuprolide Mesylate (Camcevi)
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Vutrisiran (Amvuttra)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Talazoparib (Talzenna)
CDA-AMC
2025· article· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Semaglutide (Wegovy)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Crisantaspase Recombinant (Rylaze)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Durvalumab (Imfinzi)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Givosiran (Givlaari)
Reimbursement Team
2021· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Nivolumab (Opdivo)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Ravulizumab (Ultomiris)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Momelotinib (Ojjaara)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Venetoclax (Venclexta)
CDA-AMC
2024· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pembrolizumab (Keytruda)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pegvaliase (Palynziq)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Danicopan (Voydeya)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Chemistry
machine prediction:candidate · noneconsensus · none
0
citations
affaboutunlabeled
Tirzepatide for Type 2 Diabetes Mellitus
Matthew McDonald, Kelly Farrah
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Quizartinib (Vanflyta)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Lorlatinib (Lorbrena)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Dupilumab (Dupixent)
Reimbursement Team
2021· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Ravulizumab (Ultomiris)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Amivantamab (Rybrevant)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Sacituzumab Govitecan (Trodelvy)
Reimbursement Team
2022· article· en· Canadian Journal of Health Technologies· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Pembrolizumab (Keytruda)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Lumasiran (Oxlumo)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About